Reinhard Kandera
Fortune : 4 911 $ au 31/05/2026
Fortune : 4 911 $ au 31/05/2026
Reinhard Kandera is currently the Secretary & Director at Intercell USA, Inc., the Managing Director at Elatos GmbH, and a Director at Vaccines Holdings Sweden AB. Previously, he held positions as the Secretary & Director at Valneva Scotland Ltd., the Managing Director at VALNEVA Austria GmbH, the Chief Financial Officer & Director at HOOKIPA Pharma, Inc., the Chief Financial Officer & Head-Investor Relations at Intercell AG, and the Chief Financial Officer at Valneva SE.
Dr. Kandera obtained a doctorate degree from Vienna University of Economics & Business and a graduate degree from the University of Vienna.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HOOKIPA PHARMA INC. 0,04 % | 04/06/2025 | 4 308 ( 0,04 % ) | 4 911 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IOMAI CORPORATION | Directeur/Membre du Conseil | - |
Elatos GmbH | Corporate Officer/Principal | 01/12/2013 |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| HOOA PHARPAR | Directeur Financier/CFO | 22/07/2024 |
| VALNEVA SE | Directeur Financier/CFO | - |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Directeur Financier/CFO | 28/05/2013 |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases | Corporate Officer/Principal | - |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Health Technology |
Vienna University of Economics & Business
Vienna University of Economics & Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine | Health Technology |
Valneva SE
Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases | Commercial Services |
Elatos GmbH | |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products | Health Technology |
HOOKIPA Pharma, Inc.
HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national